Pediatric COVID-19 vaccination for ages 5 to 11 deferred — DOH | Inquirer News

Pediatric COVID-19 vaccination for ages 5 to 11 deferred — DOH

By: - Reporter / @zacariansINQ
/ 04:30 PM February 03, 2022

A minor resident of La Union gets inoculated against COVID-19 during the recent pediatric vaccination drive

A minor resident of La Union gets inoculated against COVID-19 during the recent pediatric vaccination drive. The province has achieved herd immunity against viral disease. (Photo courtesy La Union provincial government)

MANILA, Philippines — The Department of Health (DOH) has postponed the pediatric COVID-19 vaccination for children aged 5 to 11 years, originally scheduled on February 4.

“The rollout for vaccinating children aged 5-11 years old will be postponed for a few days due to logistical challenges,” the DOH said in an advisory Thursday.

Article continues after this advertisement

The vaccination drive for this age group was initially scheduled on February 4 in six different sites in Metro Manila but was moved to Feb. 7, Monday.

FEATURED STORIES

DOH explained that the postponement was to ensure “adequate preparation and distribution” of the Pfizer vaccines which is set to arrive on Feb. 4, Friday, the same day the inoculation drive was supposed to start.

As of writing, only Pfizer’s COVID-19 vaccine has been given emergency use authorization for kids aged five to 11.

EDV
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: coronavirus Philippines, Pfizer

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.